← Back to Search

Psychotherapy for Long COVID

N/A

Waitlist Available

Led By Marianne S. Goodman, MD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 18-80

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up this outcome will be measured at 2 time points: consent & baseline and immediately post intervention (after the second 8 sessions)

Awards & highlights

Study Summary

This trial will test a new psychotherapeutic group intervention called PACS Coping and Recovery (PACS-CR) to help Veterans suffering from Post-Acute COVID-19 Syndrome (PACS). The study will have two stages: first, the treatment materials will be tested and refined using feedback from Veterans, then a pilot study will be conducted to assess the feasibility and acceptability of the treatment.

Who is the study for?

This trial is for U.S. Veterans aged 18-80 with Long COVID, who are clinically stable to join group therapy and use VA services at the JJPVAMC. Participants must have had a positive COVID-19 test and symptoms lasting over a month. Those with severe mental impairment, inability to engage in groups, or active substance dependence can't join.Check my eligibility

What is being tested?

The LCCR Intervention is being tested for its ability to help veterans cope with Long COVID by improving psychological adjustment, resilience, and coping skills using established psychotherapeutic techniques in a group setting.See study design

What are the potential side effects?

As this is a psychotherapeutic intervention focusing on mental health recovery rather than medication or medical procedures, traditional physical side effects are not expected; however emotional discomfort may arise as part of the therapeutic process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ this outcome will be measured at 2 time points: consent & baseline and immediately post intervention (after the second 8 sessions)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~this outcome will be measured at 2 time points: consent & baseline and immediately post intervention (after the second 8 sessions)

This trial's timeline: 3 weeks for screening, Varies for treatment, and this outcome will be measured at 2 time points: consent & baseline and immediately post intervention (after the second 8 sessions) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Functional Improvement Post-COVID-19 Over Time

Secondary outcome measures

Change in Anxiety Over Time

Change in Depression Over Time

Change in Health-Related Functional Status Over Time

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Long COVID Coping and Recovery (LCCR) InterventionExperimental Treatment1 Intervention

Veterans will participate in a LCCR (1x/week for a total of 16 sessions) via the HIPAA-compliant telehealth platform VA Video Connect (VVC) and/or VA WebEx with two co-therapists.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,609 Previous Clinical Trials

3,306,581 Total Patients Enrolled

15 Trials studying COVID-19

413,202 Patients Enrolled for COVID-19

Marianne S. Goodman, MDPrincipal InvestigatorJames J. Peters Veterans Affairs Medical Center

2 Previous Clinical Trials

284 Total Patients Enrolled

Media Library

PACS Coping and Recovery (PACS-CR) Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05453201 — N/A

COVID-19 Research Study Groups: Long COVID Coping and Recovery (LCCR) Intervention

COVID-19 Clinical Trial 2023: PACS Coping and Recovery (PACS-CR) Intervention Highlights & Side Effects. Trial Name: NCT05453201 — N/A

PACS Coping and Recovery (PACS-CR) Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05453201 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects have enrolled in the research trial?

"Affirmative, based on the data from clinicaltrials.gov this study is actively recruiting patients. It was first posted on October 1st 2022 and last updated 13th of that same month. 36 participants need to be recruited for this experiment at a single site."

Answered by AI

Is there still availability for participants to partake in this research?

"Affirmative. The trial's listing on clinicaltrials.gov confirms that recruitment is underway since October 1st 2022 and was last updated october 13th 2022. 36 participants are required to be enrolled from a single medical centre."

Answered by AI

Is the cutoff age for inclusion into this research project 35 years or above?

"The clinical trial in question accepts participants between the age of 18 and 80. Those under 18 may refer to one of 509 trials available for minors, whereas those over 65 can look into 1,858 separate studies tailored to them."

Answered by AI

Do I meet the criteria for participating in this scientific experiment?

"36 individuals suffering from the disorder, aged between 18 and 80 years old, are eligible to participate in this trial. Notably, applicants must be U.S. veterans that have been receiving mental health services at JJPVA as well as meet medical stability requirements assessed by a healthcare professional. Additionally, participants should demonstrate impairment on any of the nine domains of psychological functioning listed in the Symptom Checklist-90 Revised (Derogatis 1977), plus test positive for PACS either through PCR or antibody blood tests with symptoms persisting for one month or longer post-infection."

Answered by AI